Latest Production News

Challenger Limited posted a robust first half of FY25, with normalised net profit after tax rising 12% to $225 million, underpinned by strong Life and Funds Management segments despite softer annuity sales. The company maintains a confident outlook for FY25, forecasting further profit growth.

Challenger Limited reported a robust 12% increase in normalized NPAT to $225 million for 1H25, underpinned by strong earnings, dividend growth, and strategic investments in technology and distribution channels.

Challenger Limited reported a robust first half of FY25, delivering a 12% rise in normalised net profit after tax and record annuity sales, underpinned by strategic technology investments and longer tenor products.

Challenger Limited reported a robust 28% increase in statutory net profit after tax to $72 million for 1H25, alongside a 12% rise in normalised net profit and a higher interim dividend. Despite a 12% decline in total life sales, the company’s assets under management grew 12% to $131 billion, reflecting strong operational momentum.

Reliance Worldwide Corporation Limited reported a solid 14.8% increase in net sales for the first half of FY25, driven by the Holman acquisition and organic growth, yet signals a cautious outlook for the remainder of the year amid persistent macroeconomic headwinds.

Reliance Worldwide Corporation Limited has announced an ordinary dividend of USD 0.025 per share for the six months ending December 31, 2024, payable in April 2025. The dividend is unfranked and will be paid in Australian dollars based on a recent exchange rate.

Judo Bank reported a robust first half of FY25, delivering a 33% increase in underlying profit before tax driven by strong lending growth and improved margins. The bank is advancing its regional expansion with plans for 10 new locations and 20 additional bankers in FY25.

Propell Holdings Limited reported a 75% surge in revenue driven by a rapidly expanding loan book, yet losses more than doubled amid rising impairments. The company is navigating growth challenges while engaging with the ASX on potential delisting.

Citigroup Global Markets Australia has announced a partially franked dividend of AUD 2.15 for COH CitiFirst Instalments, with key dates set for March and April 2025.

Citigroup Global Markets Australia has announced a 45-cent unfranked dividend for its CitiFirst Self-Funding Instalment MINIs, with key dates aligned to CPU ordinary shares. The dividend will reduce outstanding loan amounts for MINI holders, impacting their financial positions.

Icetana Limited has successfully closed its renounceable pro rata entitlement offer, raising $629,422 through new share issuance, with convertible notes poised to convert into shares shortly.

Neurizon Therapeutics reported a sharp rise in half-year losses to $7.28 million but marked significant progress with its lead drug NUZ-001 entering a major ALS clinical trial and securing critical regulatory designations.